There are 3161 resources available
1058P - Hyperprogressive disease during immune checkpoint inhibitor: A cloudy phenomenon with real consequences
Presenter: Damien Bruyat
Session: Poster session 03
1059P - Association between tumor longevity and immune-checkpoint inhibitor outcomes: A retrospective study in head and neck, lung, renal/urothelial cancers
Presenter: Rebecca Romanò
Session: Poster session 03
1060P - Comparative investigation of neoadjuvant immunotherapy versus adjuvant immunotherapy in perioperative patients with cancer: A metrology informatics analysis based on machine learning
Presenter: Song-Bin Guo
Session: Poster session 03
1061P - Assessing differential informative censoring in control and experimental arm in trials testing immunotherapy in metastatic cancers: A systematic review
Presenter: Filippo Vitale
Session: Poster session 03
1062P - Effect of the immunological circadian rhythm on the treatment of locally advanced non-small cell lung cancer treated with consolidation immunotherapy
Presenter: Èlia Sais
Session: Poster session 03
1063P - Influence of infusion timing on the outcomes of immunotherapy in a multi-tumor cohort
Presenter: Víctor Albarrán Fernández
Session: Poster session 03
1064P - Optimizing infusion rates of monoclonal antibodies to save time for oncology day care and patients
Presenter: Elisabeth Cornelia Suzanne de Boer
Session: Poster session 04
1065P - Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC
Presenter: Leonardo Brunetti
Session: Poster session 04
1066P - Potential effects of olanzapine: Enhancing the immune response to PD-1/PD-L1 inhibitors
Presenter: yan ling Yi
Session: Poster session 04
Resources:
Abstract